New Discovery Links Cancer Signaling Pathway to Blood-Brain and Blood-Retina Barrier Functions
Recent research uncovers a novel link between cancer signaling pathways, specifically MDM2-p53, and the regulation of blood-brain and blood-retina barriers, with implications for neurological and ocular health.
A recent study led by researchers from the University of Minnesota Medical School has revealed a surprising connection between cancer-related cellular pathways and the vascular functions of the retina and the brain. The team found that the MDM2-p53 signaling axis, well-known for its role in tumor suppression, also plays a significant role in maintaining the integrity of blood vessels in the central nervous system, including the retina.
Published in Science Signaling, the research demonstrates that p53, a critical protein in cancer prevention, can influence blood vessel health by downregulating NCAPH, a protein involved in vascular stability. This interaction appears to weaken the Norrin/Frizzled4 signaling pathway, which is essential for the development and maintenance of blood-tissue barriers such as the blood-brain barrier and the blood-retina barrier.
Blood-CNS barriers are crucial in regulating the exchange of nutrients and waste between the bloodstream and the nervous system, preventing issues like edema and neuroinflammation. The study highlights that increasing p53 levels, a strategy used in some cancer therapies, might inadvertently compromise these barriers, potentially leading to increased vascular permeability, neuroinflammation, and swelling.
Furthermore, the research identifies NCAPH as a potential candidate gene for familial exudative vitreoretinopathy (FEVR), a rare inherited eye condition affecting retinal blood vessels. These findings suggest caution in using MDM2 inhibitors—drugs that elevate p53—in cancer treatment, as they could disrupt vascular barrier functions.
The study emphasizes the need for further research into how modulation of p53 may impact vascular health, especially in the context of neurological and ocular diseases. It also opens avenues for exploring NCAPH as a target for vascular disorder therapeutics.
For more information, see the full study: Jacklyn Levey et al, The MDM2-p53 axis regulates norrin/frizzled4 signaling and blood-CNS barrier function, Science Signaling (2025). For details, visit: https://medicalxpress.com/news/2025-07-uncovers-link-cancer-pathway-blood.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
CDC Reports Nearly One-Third of U.S. Youth Have Prediabetes Amid Data Transparency Concerns
Recent CDC data reveals nearly one-third of U.S. adolescents have prediabetes, raising public health concerns amid questions about data transparency and methodology.
Innovative Imaging Technique Connects Inner Ear Fluid Levels with Hearing Loss Severity
A new application of optical coherence tomography (OCT) offers a faster, more precise way to assess inner ear fluid levels, improving diagnosis and treatment of hearing loss conditions like Ménière's disease. This cutting-edge technique could revolutionize audiology by enabling real-time, non-invasive monitoring of inner ear health.
Innovative AI Technology Enhances Chest X-ray Diagnostics
Arizona State University has developed Ark+, an open-access AI system that significantly improves the accuracy and speed of chest X-ray diagnosis, outperforming industry-proprietary solutions. This innovative tool aims to democratize healthcare technology and assist doctors worldwide in detecting a broad spectrum of lung and chest conditions.
Stalling Progress in Childhood Vaccination Coverage Threatens Global Health Goals
Recent data reveals a slowdown in childhood vaccination rates worldwide, risking outbreaks of preventable diseases. Addressing disparities and pandemic disruptions is key to achieving global immunization goals by 2030.